TERENCE ANTHONY RUGG Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for TERENCE ANTHONY RUGG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of TERENCE ANTHONY RUGG. TERENCE ANTHONY RUGG is Chief Medical Officer in Sonnet BioTherapeutics Holdings, Inc. ($HOTR) and CMO & VP, Drug Development in SGX PHARMACEUTICALS, INC. ($SGXP) and VP, Chief Medical Officer in SGX PHARMACEUTICALS, INC. ($SGXP).
Latest Insider Trading Transactions of TERENCE ANTHONY RUGG
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 02 2020 | HOTR | Sonnet BioTherapeu ... | RUGG TERENCE ANTHONY | Chief Medical Offic ... | Grant | A | 0.00 | 21,314 | 0 | 21,314 | 0 to 21.3 K |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | D | 4.75 | 3,948 | 18,753 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | D | 3.99 | 18,523 | 73,907 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | D | 3.63 | 31,741 | 115,220 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | D | 4.75 | 71,052 | 337,497 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | D | 3.99 | 7,627 | 30,432 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | D | 3.63 | 18,259 | 66,280 | 0 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | A | 3.99 | 18,523 | 73,907 | 18,523 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | A | 3.99 | 7,627 | 30,432 | 7,627 | |
| Jan 29 2007 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | A | 3.63 | 31,741 | 115,220 | 31,741 | |
| Jan 29 2007 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | A | 3.63 | 18,259 | 66,280 | 18,259 | |
| Aug 15 2006 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | VP, Chief Medical O ... | Option Exercise | A | 4.75 | 3,948 | 18,753 | 3,948 | |
| Aug 15 2006 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | VP, Chief Medical O ... | Option Exercise | A | 4.75 | 71,052 | 337,497 | 71,052 |
Page: 1